ASX:NSB (Australia)
Â
Ordinary Shares
A$
0.03
(-2.94%)
Dec 27
Business Description
Neuroscientific Biopharmaceuticals Ltd
ISIN : AU0000012973
Share Class Description:
ASX:NSB: Ordinary SharesDescription
Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and therapeutic treatments for neurodegenerative diseases through preclinical studies of patented technologies.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.98 | |||||
| Piotroski F-Score | 5/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | -28.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.84 | |||||
| 9-Day RSI | 39.38 | |||||
| 14-Day RSI | 41.9 | |||||
| 6-1 Month Momentum % | -10.26 | |||||
| 12-1 Month Momentum % | -12.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 58.65 | |||||
| Quick Ratio | 58.65 | |||||
| Cash Ratio | 57.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.3 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | 7.02 | |||||
| ROA % | 6.63 | |||||
| ROIC % | -524.94 | |||||
| ROC (Joel Greenblatt) % | 1757.89 | |||||
| ROCE % | 7.23 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.5 | |||||
| PE Ratio without NRI | 16.5 | |||||
| Price-to-Owner-Earnings | 11.33 | |||||
| PB Ratio | 0.89 | |||||
| Price-to-Tangible-Book | 1.1 | |||||
| EV-to-EBIT | -0.11 | |||||
| EV-to-EBITDA | -0.09 | |||||
| EV-to-FCF | -0.88 | |||||
| Price-to-Graham-Number | 0.83 | |||||
| Price-to-Net-Current-Asset-Value | 1.1 | |||||
| Price-to-Net-Cash | 1.1 | |||||
| Earnings Yield (Greenblatt) % | -909.09 | |||||
| FCF Yield % | 0.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Neuroscientific Biopharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | |||
| EPS (TTM) (A$) | 0.002 | ||
| Beta | 1.39 | ||
| Volatility % | 61.96 | ||
| 14-Day RSI | 41.9 | ||
| 14-Day ATR (A$) | 0.001025 | ||
| 20-Day SMA (A$) | 0.03535 | ||
| 12-1 Month Momentum % | -12.5 | ||
| 52-Week Range (A$) | 0.033 - 0.078 | ||
| Shares Outstanding (Mil) | 144.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Neuroscientific Biopharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Neuroscientific Biopharmaceuticals Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Neuroscientific Biopharmaceuticals Ltd Frequently Asked Questions
What is Neuroscientific Biopharmaceuticals Ltd(ASX:NSB)'s stock price today?
The current price of ASX:NSB is A$0.03. The 52 week high of ASX:NSB is A$0.08 and 52 week low is A$0.03.
When is next earnings date of Neuroscientific Biopharmaceuticals Ltd(ASX:NSB)?
The next earnings date of Neuroscientific Biopharmaceuticals Ltd(ASX:NSB) is .
Does Neuroscientific Biopharmaceuticals Ltd(ASX:NSB) pay dividends? If so, how much?
Neuroscientific Biopharmaceuticals Ltd(ASX:NSB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers